Geron
GERN
$3.84
Share price
4.21%
Change (1 day)
87.07%
Change (1 year)
Categories
Revenue for Geron (GERN)
Revenue in 2023 (TTM): $0.23 M
According to Geron's latest financial reports the company's current revenue (TTM) is $0.23 M. In 2022 the company made a revenue of $0.59 M a decrease over the years 2021 revenue that were of $1.39 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Geron from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.23 M | -60.23% |
| 2022 | $0.59 M | -57.21% |
| 2021 | $1.39 M | 450.59% |
| 2020 | $0.25 M | -45% |
| 2019 | $0.46 M | -56.85% |
| 2018 | $1.06 M | 0.09% |
| 2017 | $1.06 M | -82.72% |
| 2016 | $6.16 M | -83.06% |
| 2015 | $36.37 M | 3054.47% |
| 2014 | $1.15 M | -10.13% |
| 2013 | $1.28 M | -52.64% |
| 2012 | $2.7 M | 11.12% |
| 2011 | $2.43 M | -31.57% |
| 2010 | $3.56 M | 106.43% |
| 2009 | $1.72 M | -38.42% |
| 2008 | $2.8 M | -63.22% |
| 2007 | $7.62 M | 132.59% |
| 2006 | $3.27 M | 1030% |
| 2005 | $0.29 M | |
| 2003 | $0.94 M | -16.62% |
| 2002 | $1.13 M | -68.59% |
| 2001 | $3.62 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $27.11 B | 11,440,828.27% | 🇺🇸 USA |
 Incyte INCY | $3.69 B | 1,559,245.57% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $75.76 M | 31,870.04% | 🇺🇸 USA |
 Bio-Techne TECH | $1.14 B | 483,021.94% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $0.06 M | -71.31% | 🇺🇸 USA |